EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

2023 Diabetic Kidney Disease Fact Sheet in Korea

Nam Hoon Kim, Mi-Hae Seo, Jin Hyung Jung, Kyung Do Han, Mi Kyung Kim, Nan Hee Kim

Diabetes & Metabolism Journal · 2024

DOI: 10.4093/dmj.2023.0310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, 2024. Verfasst von Nam Hoon Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Kidney Failure, Chronic, Comorbidity. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the prevalence, incidence, comorbidities, and management status of diabetic kidney disease (DKD) and diabetes-related end-stage kidney disease (ESKD) in South Korea.

Methods

We used the Korea National Health and Nutrition Examination Survey data (2019 to 2021, n=2,665) for the evaluation of prevalence, comorbidities, control rate of glycemia and comorbidities in DKD, and the Korean Health Insurance Service-customized database (2008 to 2019, n=3,950,857) for the evaluation of trends in the incidence and prevalence rate of diabetes-related ESKD, renin-angiotensin system (RAS) blockers and sodium glucose cotransporter 2 (SGLT2) inhibitors use for DKD, and the risk of atherosclerotic cardiovascular disease (ASCVD) and mortality according to DKD stages. DKD was defined as albuminuria or low estimated glomerular filtration rate (eGFR)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesKidney Failure, ChronicComorbidityHumansRepublic of KoreaMaleFemaleMiddle AgedPrevalenceAgedAdultIncidenceNutrition SurveysGlomerular Filtration RateDiabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsRisk Factors

Stichwörter der Autor:innen

Cardiovascular diseasesDiabetic nephropathiesEpidemiologyIncidencePrevalence

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Korea.
  • Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Korea.
  • Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
  • Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.

Zitieren

APA

Kim, N. H., Seo, M. H., Jung, J. H., Han, K. D., Kim, M. K., & Kim, N. H. (2024). 2023 Diabetic Kidney Disease Fact Sheet in Korea. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2023.0310

Vancouver

Kim NH, Seo MH, Jung JH, Han KD, Kim MK, Kim NH. 2023 Diabetic Kidney Disease Fact Sheet in Korea. Diabetes & Metabolism Journal. 2024. doi:10.4093/dmj.2023.0310

BibTeX
@article{Kim2024,
  author = {Kim, Nam Hoon and Seo, Mi-Hae and Jung, Jin Hyung and Han, Kyung Do and Kim, Mi Kyung and Kim, Nan Hee},
  title = {2023 Diabetic Kidney Disease Fact Sheet in Korea},
  journal = {Diabetes & Metabolism Journal},
  year = {2024},
  doi = {10.4093/dmj.2023.0310}
}
Kostenlos starten →